Marshall Wace’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Buy |
112,382
+95,158
| +552% | +$13.1M | 0.02% | 613 |
|
|
2025
Q1 | $3.11M | Buy |
17,224
+6,893
| +67% | +$1.24M | ﹤0.01% | 1187 |
|
|
2024
Q4 | $1.62M | Buy |
+10,331
| New | +$1.62M | ﹤0.01% | 1417 |
|
|
2024
Q2 | – | Sell |
-5,600
| Closed | -$996K | – | 2495 |
|
|
2024
Q1 | $996K | Sell |
5,600
-65,301
| -92% | -$11.6M | ﹤0.01% | 1439 |
|
|
2023
Q4 | $8.8M | Buy |
70,901
+61,373
| +644% | +$7.61M | 0.01% | 612 |
|
|
2023
Q3 | $1.11M | Buy |
+9,528
| New | +$1.11M | ﹤0.01% | 1239 |
|
|
2023
Q2 | – | Sell |
-8,571
| Closed | -$686K | – | 2262 |
|
|
2023
Q1 | $686K | Sell |
8,571
-3,629
| -30% | -$291K | ﹤0.01% | 1539 |
|
|
2022
Q4 | $966K | Buy |
+12,200
| New | +$966K | ﹤0.01% | 1611 |
|
|
2022
Q1 | – | Sell |
-108,511
| Closed | -$7.59M | – | 2969 |
|
|
2021
Q4 | $7.59M | Buy |
108,511
+82,856
| +323% | +$5.8M | 0.01% | 984 |
|
|
2021
Q3 | $1.34M | Buy |
+25,655
| New | +$1.34M | 0.01% | 1410 |
|
|
2021
Q2 | – | Sell |
-29,836
| Closed | -$2.3M | – | 2321 |
|
|
2021
Q1 | $2.3M | Buy |
29,836
+22,409
| +302% | +$1.73M | 0.01% | 1088 |
|
|
2020
Q4 | $446K | Buy |
+7,427
| New | +$446K | ﹤0.01% | 1367 |
|